Insights
Environmental sustainability in the NHS 10 Year Health Plan: The need for green
29 September 2025
This is the second in a series of blogs about how the proposals in the recently published 10 Year Plan measure up against some of the most pressing health concerns in the UK.
Around the World in HTAs: Saudi Arabia – Navigating the healthcare and HTA landscape
24 September 2025
The next stop in our around the world in HTAs adventure is Saudi Arabia. This blog breaks down how the Kingdom is reshaping access to new health technologies through regulatory reform, a formal HTA framework, and value-based care. It provides a comprehensive overview of the structural and regulatory reforms underway as part of Vision 2030, highlighting how these changes are reshaping the way new health technologies are evaluated, priced, and brought to market.
The true cost and burden of frontotemporal dementia: Early insights into a pressing challenge
22 September 2025
In recognition of Frontotemporal Dementia Awareness Week, OHE shares ongoing work quantifying the disease burden and cost-of-illness associated with FTD.
Prevention in the NHS 10 Year Health Plan: Promise, limits, and the path forward
17 September 2025
This is the first in a series of blogs about how the proposals in the newly published 10 Year Plan measure up against some of the most pressing health concerns in the UK.
Around the world in HTAs: China – From fragmentation to function
2 September 2025
In this Insights series, Around the World in HTAs, we shed light on HTA around the world. In this edition, Meng Li, Claud Theakston and Yawen Jiang take us to China.
Climate action is health action: OHE’s focus on sustainability
22 July 2025
At the intersection of health and the climate is an urgent crisis. This crisis affects health in ways that are wide-ranging, unevenly distributed, and difficult to isolate. It poses deep challenges not only for service delivery but for how we define value, whose preferences we measure, and how we account for intergenerational and regional equity.
From STEDI to STRIDES: Valuing broader health-system benefits of AMR diagnostics
21 July 2025
Antimicrobial resistance (AMR) is an urgent global health crisis. AMR infections cause an estimated 1.3 million deaths globally every year, and this number is only projected to rise.
Reflections from the Region: Healthcare transformation in the Middle East
18 June 2025
It’s not often that you witness a health system reinvent itself in real-time. And yet, this is precisely what is happening across the Middle East.
The Trump Administration’s US Drug Pricing Proposal – What will happen next?
12 June 2025
This is the second in our series of Insights considering the implications of President Trump’s Executive Order on ‘Most Favoured Nation’ drug pricing. We know that…